RenX Enterprises Corp. filed a preliminary proxy statement on November 20, 2026, calling a Special Meeting of Stockholders to vote on six proposals, including conversion approvals for Series C and Series D Preferred Stock, a senior convertible note conversion, an authorized share increase, and a reverse stock split.
Key Highlights
- Series C Conversion: Stockholders are asked to approve the issuance of 4,779,333 shares of common stock upon conversion of 7,169 shares of Series C Convertible Preferred Stock issued to Index Equity US, LLC under an Exchange Agreement dated June 11, 2026.
- Series D Conversion: Stockholders are asked to approve the issuance of 960,667 shares of common stock upon conversion of 1,441 shares of Series D Convertible Preferred Stock issued to James Burnham under an Exchange Agreement dated September 30, 2026.
- Note Conversion: Stockholders are asked to approve issuance of up to 2,136,728 shares of common stock upon conversion of a senior convertible note with a principal amount of $1,037,283.93, issued under an Exchange Agreement dated November 2, 2026, with an accredited investor.
- Authorized Share Increase: A proposal would increase authorized shares of common stock from 500,000,000 to 525,000,000 shares.
- Reverse Stock Split: The Board seeks authority to effect a reverse stock split at a ratio ranging from 1-for-5 to 1-for-25, with the final ratio to be determined at the Board's discretion.
- Record Date: The record date for the Special Meeting has been fixed as the close of business on October 28, 2026.
RenX Enterprises Calls Special Meeting for Conversion, Share Structure Votes
According to the preliminary proxy statement, RenX Enterprises Corp. (NASDAQ:RENX), headquartered at 990 Biscayne Boulevard, Suite 501, Miami, Florida 33132, has called a Special Meeting of Stockholders to be held at the offices of Blank Rome LLP, 1271 Avenue of the Americas, 16th Floor, New York, New York 10020, beginning at 10:00 a.m. Eastern Time in December 2026. The filing states that all six proposals are being submitted for purposes of complying with Nasdaq Rule 5635(d) or amending the company's Certificate of Incorporation.
The filing discloses that the Series C Preferred Stock was issued pursuant to an Exchange Agreement dated June 11, 2026, with Index Equity US, LLC, and that the Series D Preferred Stock was issued pursuant to an Exchange Agreement dated September 30, 2026, with James Burnham. Each conversion proposal also covers additional shares of common stock that may become issuable as a result of any dividend payment or adjustment to the conversion price, according to the proxy statement. The Note, with a stated principal of $1,037,283.93, was described as accruing interest at 10% for 12 months, with any conversion price potentially reduced to a floor price.
The proxy statement also describes two amendments to the company's Amended and Restated Certificate of Incorporation: one to increase authorized common shares from 500,000,000 to 525,000,000, and one to allow the Board to effect a reverse stock split at a ratio within the range of 1-for-5 to 1-for-25. The filing notes that the final ratio would be determined at the Board's discretion and included in a public announcement. The proxy was signed by David Villarreal, identified in the filing as Chief Executive Officer and Director.
What Was Disclosed
RenX Enterprises Corp. filed a preliminary proxy statement calling a Special Meeting to vote on six proposals: three share issuance approvals tied to preferred stock and note conversions, an authorized share increase from 500,000,000 to 525,000,000, a reverse stock split in a 1-for-5 to 1-for-25 range, and a possible adjournment.



Please wait processing your request...